[ad_1]
The French conglomerate said it has now completed a study showing the feasibility of listing its Canal+ subsidiary on the London Stock Exchange in what would be a major win for the troubled market
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...